What is RO.SW's current stock price?

RO.SW (Roche Holding AG) is currently trading at $332.60 with a market cap of $264.75B.

What sector is Roche Holding AG in?

Roche Holding AG (RO.SW) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.

InvestLog

Back to Market返回行情

RO.SW Roche Holding AG

SIXHealthcare

$332.60-1.19%ClosedMarket Cap: $264.75B

As of 2026-06-01 05:24

Valuation

View Details

P/E (TTM)

20.10

PEG

—

P/B

7.66

P/S

4.21

EV/EBITDA

12.58

DCF Value

—

FCF Yield

4.6%

Div Yield

3.0%

Margins & Returns

Gross Margin

73.5%

Operating Margin

28.9%

Net Margin

20.9%

ROE

41.2%

ROA

12.8%

ROIC

18.8%

Financials

View All

Period	Revenue	Net Income	EPS
Q4 2025	$30.57B	$5.47B	$6.81
Q2 2025	$30.94B	$7.41B	$9.23
Q4 2024	$31.64B	$2.02B	$2.52
Q2 2024	$30.76B	$6.26B	$7.78

Latest News

Roche to present new data advancing its obesity portfolio at the American Diabetes Association’s 2026 Scientific SessionsGlobe News Wire · 2026-06-01

Roche launches the Liver Disease Panel, the first suite of certified algorithms to support Chronic Liver Disease managementGlobe News Wire · 2026-05-27

Roche to present new data at ASCO 2026, reinforcing giredestrant's potential to transform the treatment paradigm in early breast cancerGlobe News Wire · 2026-05-19

Roche receives CE mark for new blood test to detect Alzheimer's pathology: Elecsys® plasma phosphorylated-tau 217 (pTau217)Globe News Wire · 2026-05-12

Roche enters into a definitive merger agreement to acquire PathAI to transform AI-driven diagnosticsGlobe News Wire · 2026-05-07

Listing Info

Market

Exchange

SIX

Currency

USD

Sector

Healthcare

Industry

Drug Manufacturers - General

Country

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.